Person profile
Public information reviewedCharles Newton
Board role
Director · Keros Therapeutics, Inc. (NASDAQ: KROS)
Keros Therapeutics, Inc. (NASDAQ: KROS)
Director · Current mandate
- Public sources
- 1 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- Sep 6, 2026
Alpha Registry